Athpharma Limited
Records under this name other than patents Athpharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Athpharma Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,849,661 | Treatment of Abnormal Increases in Gastrointestinal Motility with (R)-Verapamil Formerly held Term ended Term ended Nov 24, 2022 · Medium confidence | Term ended | Term ended Nov 24, 2022 | Medium confidence |
| US 8,987,322 | Pharmaceutical formulations for carrier-mediated transport statins and uses thereof Formerly held Lapsed on the fee record Ended Mar 24, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 24, 2019 | USPTO record |
| US 6,967,218 | Pravastatin Pharmaceutical Formulations and Methods of Their Use Formerly held Lapsed on the fee record Ended Nov 22, 2017 · High confidence | Lapsed on the fee record | Ended Nov 22, 2017 | High confidence |
| US 6,733,789 | Multiparticulate bisoprolol formulation Formerly held Lapsed on the fee record Ended May 11, 2012 · USPTO record | Lapsed on the fee record | Ended May 11, 2012 | USPTO record |
| US 7,098,232 | Treatment and prevention of gastrointestinal disease using antagonists of partial agonists of 5HT1a receptors Lapsed on the fee record Ended Aug 29, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2010 | USPTO record |
| US 6,641,839 | Pharmaceutical formulations for preventing drug tolerance Formerly held Term ended Term ended Dec 30, 2009 · USPTO record | Term ended | Term ended Dec 30, 2009 | USPTO record |
| US 5,892,093 | Resolution Formerly held Term ended Term ended no later than Apr 6, 2019 · Low confidence | Term ended | Term ended no later than Apr 6, 2019 | Low confidence |